The HCPLive conference coverage page features articles, videos, and expert-led live coverage from major medical meetings throughout the year.
November 19th 2021, 7:00pm
At AAO 2021, Dr. Sahel discussed the findings of the PIONEER trial on the combination of an optogenetics device and gene therapy in treatment of RP.
November 17th 2021, 8:00pm
Dr. Avery discusses the positive results of RGX-314 gene therapy, noting dramatic reduction in need for therapy, with stable vision and good thickness results
November 16th 2021, 10:00pm
Dr. Dhoot discusses data on visual acuity from the phase 3 KESTREL and KITE trials, comparing brolucizumab to aflibercept at 52 weeks.
November 16th 2021, 9:00pm
Investigators said that patient-reported outcomes from the 2 abrocitinib groups showed greater efficacy than the dupilumab and placebo groups.
November 16th 2021, 5:00pm
Respondents suggested that increasing product availability and demonstrating the consequences of sunburn could increase sun protection among young people.
November 16th 2021, 4:00pm
Dr. Khanani highlights data from MERLIN showing noninferiority of brolucizumab to aflibercept in nAMD treatment, but a higher rate of intraocular inflammation.
November 16th 2021, 1:00pm
Dr. Sheth discusses the data from the late-breaking Phase 2B ALTISSIMO study.
November 15th 2021, 10:00pm
Dr. Elewski hopes that in the future more clinicians will prescribe biologics such as secukinumab and etancercept for the treatment of psoriasis.
November 15th 2021, 8:00pm
Though Dr. Khattri felt the diagnosis of psoriatic arthritis had been “stagnant”, the inclusion of biologic therapies and more has been a welcomed change.